Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - hydrochlorothiazide, quantity: 25 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; lactose monohydrate; hyprolose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; hyprolose; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; hyprolose; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - hydrochlorothiazide, quantity: 25 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; lactose monohydrate; hyprolose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide red - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg; telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate; croscarmellose sodium; brilliant blue fcf aluminium lake; mannitol; magnesium stearate; microcrystalline cellulose; povidone; silicon dioxide; iron oxide yellow; sodium hydroxide; meglumine; iron oxide black; isomalt - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg; telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: mannitol; iron oxide black; brilliant blue fcf aluminium lake; calcium hydrogen phosphate; sodium hydroxide; iron oxide yellow; meglumine; isomalt; croscarmellose sodium; magnesium stearate; povidone; microcrystalline cellulose; silicon dioxide - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg; telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: mannitol; povidone; iron oxide black; silicon dioxide; croscarmellose sodium; calcium hydrogen phosphate; meglumine; isomalt; sodium hydroxide; brilliant blue fcf aluminium lake; iron oxide yellow; microcrystalline cellulose; magnesium stearate - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg; telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: iron oxide black; iron oxide yellow; brilliant blue fcf aluminium lake; microcrystalline cellulose; croscarmellose sodium; calcium hydrogen phosphate; silicon dioxide; meglumine; povidone; mannitol; sodium hydroxide; isomalt; magnesium stearate - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.